Pierre Hugo

The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis

Q. Bassat, N. Anstey, A. Ghani, 2020, PLoS medicine.

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis

A. Ghani, L. Okell, N. Ferguson, 2014, Nature Communications.

Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)

Kwaku Poku Asante, H. Gardarsdottir, H. Leufkens, 2018, Drug Safety.

Use of rectal artesunate for severe malaria at the community level, Zambia

C. Green, Caroline Barber, Tendayi Kureya, 2019, Bulletin of the World Health Organization.

An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study

C. Lengeler, A. Ross, C. Burri, 2015, Malaria Journal.

A comparison of the duration of post-treatment protection of artemether-lumefantrine, dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated malaria

A. Ghani, L. Okell, J. Griffin, 2014, Malaria Journal.

Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda

Kwaku Poku Asante, H. Gardarsdottir, H. Leufkens, 2019, Malaria Journal.